These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37081561)

  • 1. CD33 as a leukocyte-associated marker expressed on human spermatozoa.
    Sereshki N; Rafiee M; Alipour R; Rahimyan K; Wilkinson D
    BMC Res Notes; 2023 Apr; 16(1):57. PubMed ID: 37081561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of CD33-related siglecs on human mononuclear phagocytes, monocyte-derived dendritic cells and plasmacytoid dendritic cells.
    Lock K; Zhang J; Lu J; Lee SH; Crocker PR
    Immunobiology; 2004; 209(1-2):199-207. PubMed ID: 15481154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cloning, characterization, and phylogenetic analysis of siglec-9, a new member of the CD33-related group of siglecs. Evidence for co-evolution with sialic acid synthesis pathways.
    Angata T; Varki A
    J Biol Chem; 2000 Jul; 275(29):22127-35. PubMed ID: 10801860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The membrane-proximal immunoreceptor tyrosine-based inhibitory motif is critical for the inhibitory signaling mediated by Siglecs-7 and -9, CD33-related Siglecs expressed on human monocytes and NK cells.
    Avril T; Floyd H; Lopez F; Vivier E; Crocker PR
    J Immunol; 2004 Dec; 173(11):6841-9. PubMed ID: 15557178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ganglioside binding pattern of CD33-related siglecs.
    Rapoport E; Mikhalyov I; Zhang J; Crocker P; Bovin N
    Bioorg Med Chem Lett; 2003 Feb; 13(4):675-8. PubMed ID: 12639556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene conversions are frequent but not under positive selection in the Siglec gene families of primates.
    Zid M; Drouin G
    Genome; 2014 Jun; 57(6):317-25. PubMed ID: 25166301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of CD33-related siglecs: regulating host immune functions and escaping pathogen exploitation?
    Cao H; Crocker PR
    Immunology; 2011 Jan; 132(1):18-26. PubMed ID: 21070233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cloning and characterization of a novel mouse Siglec, mSiglec-F: differential evolution of the mouse and human (CD33) Siglec-3-related gene clusters.
    Angata T; Hingorani R; Varki NM; Varki A
    J Biol Chem; 2001 Nov; 276(48):45128-36. PubMed ID: 11579105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common determinants of severe Covid-19 infection are explicable by SARS-CoV-2 secreted glycoprotein interaction with the CD33-related Siglecs, Siglec-3 and Siglec-5/14.
    Murch SH
    Med Hypotheses; 2020 Nov; 144():110168. PubMed ID: 33254494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Siglecs: sialic-acid-binding immunoglobulin-like lectins in cell-cell interactions and signalling.
    Crocker PR
    Curr Opin Struct Biol; 2002 Oct; 12(5):609-15. PubMed ID: 12464312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basic and clinical immunology of Siglecs.
    von Gunten S; Bochner BS
    Ann N Y Acad Sci; 2008 Nov; 1143():61-82. PubMed ID: 19076345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Negative regulation of T cell receptor signaling by Siglec-7 (p70/AIRM) and Siglec-9.
    Ikehara Y; Ikehara SK; Paulson JC
    J Biol Chem; 2004 Oct; 279(41):43117-25. PubMed ID: 15292262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloid precursors and acute myeloid leukemia cells express multiple CD33-related Siglecs.
    Nguyen DH; Ball ED; Varki A
    Exp Hematol; 2006 Jun; 34(6):728-35. PubMed ID: 16728277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Siglecs, sialic acids and innate immunity.
    Crocker PR; Varki A
    Trends Immunol; 2001 Jun; 22(6):337-42. PubMed ID: 11377294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural ligands for CD33-related Siglecs?
    Varki A
    Glycobiology; 2009 Aug; 19(8):810-2. PubMed ID: 19429924
    [No Abstract]   [Full Text] [Related]  

  • 16. Sensing the neuronal glycocalyx by glial sialic acid binding immunoglobulin-like lectins.
    Linnartz-Gerlach B; Mathews M; Neumann H
    Neuroscience; 2014 Sep; 275():113-24. PubMed ID: 24924144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Siglecs as targets for therapy in immune-cell-mediated disease.
    O'Reilly MK; Paulson JC
    Trends Pharmacol Sci; 2009 May; 30(5):240-8. PubMed ID: 19359050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Siglecs: A journey through the evolution of sialic acid-binding immunoglobulin-type lectins.
    Bornhöfft KF; Goldammer T; Rebl A; Galuska SP
    Dev Comp Immunol; 2018 Sep; 86():219-231. PubMed ID: 29751010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new siglec family member, siglec-10, is expressed in cells of the immune system and has signaling properties similar to CD33.
    Whitney G; Wang S; Chang H; Cheng KY; Lu P; Zhou XD; Yang WP; McKinnon M; Longphre M
    Eur J Biochem; 2001 Dec; 268(23):6083-96. PubMed ID: 11733002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the CD33-related Siglec receptor, Siglec-5 (CD170), as a useful marker in both normal myelopoiesis and acute myeloid leukaemias.
    Virgo P; Denning-Kendall PA; Erickson-Miller CL; Singha S; Evely R; Hows JM; Freeman SD
    Br J Haematol; 2003 Nov; 123(3):420-30. PubMed ID: 14617000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.